Mixed aortic valve disease

Article written and reviewed by Dr Luca Moretti

Mixed aortic valve disease is the coexistence of stenosis and regurgitation in the same aortic valve. During systole, the narrowed orifice obstructs ejection; during diastole, a portion of blood returns from the aorta to the left ventricle. The myocardium is therefore exposed simultaneously to pressure and volume overload, a condition that differs from both isolated stenosis and isolated regurgitation and may impose a greater burden than suggested by two components graded separately as moderate.

Diagnosis is not simply the reporting of two echocardiographic grades. The regurgitant volume is ejected again through the valve and increases total systolic flow: velocity and gradient may therefore be high even when valve area does not meet criteria for severe stenosis. At the same time, hypertrophy and dilatation coexist, ejection fraction may remain apparently normal, and the usual ventricular thresholds derived from isolated regurgitation may fail to identify damage early.

When one component is severe and the other mild or moderate, the predominant lesion guides management. The specific challenge is the balanced form, particularly moderate stenosis combined with moderate regurgitation. Observational studies show frequent events and emphasize the prognostic value of transvalvular velocity; the 2025 European guidelines introduced explicit recommendations for some of these patients, despite the absence of large dedicated randomized trials.

Assessment must also distinguish the valve from the aortic root and ascending aorta. A bicuspid valve may become stenotic and lose coaptation, whereas root dilatation contributes to regurgitation and carries a separate aortic risk. The choice between surgical and transcatheter replacement therefore depends not only on valvular burden, but also on age, anatomy, coronary arteries, aorta, durability and the need for concomitant procedures.

Etiology, anatomy and combined pathophysiology

The most common cause in high-income countries is calcific degeneration of a tricuspid or bicuspid aortic valve. Calcium stiffens the leaflets, narrows the opening and may impair coaptation; in bicuspid valve disease, asymmetry and the raphe promote both defects at a younger age. Associated aortopathy must be described by root or ascending phenotype and family history, because it may become the dominant indication for surgery.

Rheumatic disease causes commissural fusion, thickening and retraction, often together with mitral involvement. Endocarditis affecting an already stenotic valve may cause perforation or destruction and generate acute regurgitation; radiation therapy, connective tissue disorders and inflammatory diseases are less common causes. Previous commissurotomy or repair may leave a persistently narrowed orifice together with new regurgitation.

In isolated stenosis, the ventricle responds with concentric hypertrophy to normalize systolic wall stress. In isolated regurgitation, end-diastolic volume increases and hypertrophy is eccentric. In mixed disease, wall thickness and cavity size increase together but in variable proportions: the ventricle may not reach the large dimensions typical of isolated regurgitation despite sustaining high stress and developing fibrosis.

In aortic regurgitation, total stroke volume includes both effective forward output and the portion that will return to the ventricle during diastole. If the valve is also stenotic, the entire flow crosses a narrowed orifice and may produce a higher velocity than expected from valve area alone: a high Vmax therefore reflects the overall workload imposed on the ventricle, not merely an artifact. Other high-output states, such as anemia, fever, hyperthyroidism or shunts, must nevertheless be excluded before attributing the finding to mixed valve disease.

During diastole, regurgitation depends on orifice size, the aorta-to-ventricle pressure gradient and diastolic duration. Stenosis tends to maintain systolic aortic pressure and afterload, whereas reflux may lower diastolic pressure and widen pulse pressure. Subendocardial coronary perfusion is exposed simultaneously to increased demand from hypertrophy and potentially lower diastolic pressure, contributing to angina even in the absence of coronary stenoses.

Ventricular compliance determines symptoms and measurements. A stiff ventricle develops elevated filling pressures early, with left atrial and pulmonary vascular involvement despite the absence of extreme chamber enlargement; a more compliant ventricle accumulates volume at initially low pressures and may appear clinically compensated. Age, hypertension, ischemia and fibrosis modify this response and explain why patients with similar valve grades may follow different trajectories.

As disease progresses, contractile reserve declines, longitudinal strain worsens and ejection fraction may fall. In regurgitation, part of the stroke volume is ejected toward a lower-impedance pathway; in stenosis, ejection meets an obstruction. An ejection fraction of 50% already represents relevant dysfunction in mixed disease and should not be regarded as nearly normal.

Remodeling is not necessarily uniform. Sex, body size, hypertension and valve phenotype influence mass and volumes; absolute values may underestimate abnormality in a small ventricle or overestimate it in a large one. Indexing, trajectory and comparison with appropriate reference ranges are essential. Strain may signal functional loss before ejection fraction falls, but no disease-specific threshold independently authorizes intervention in mixed aortic valve disease.

Clinical presentation, cardiac damage and natural history

Mild forms may remain asymptomatic for years, but as the load increases, dyspnea, reduced functional capacity, angina, presyncope or syncope progressively emerge, while orthopnea and edema indicate the onset of heart failure. Patients often unconsciously reduce their activity and may therefore underestimate decline; serial history taking and exercise testing become particularly useful when a moderate-moderate combination appears disproportionate to reported symptoms.

On physical examination, signs of the two components may partially offset one another: regurgitation tends to produce a bounding pulse, whereas stenosis causes a delayed upstroke. The systolic ejection murmur typically radiates to the carotids, the decrescendo diastolic murmur is heard along the left sternal border, and an Austin Flint murmur may occur with important regurgitation. None of these findings, however, precisely separates the contribution of the two lesions, and an unimpressive examination does not exclude a severe hemodynamic burden.

The ECG may show hypertrophy and repolarization abnormalities, sometimes conduction block or atrial fibrillation; chest radiography may show ventricular and aortic dilatation. Natriuretic peptides reflect wall stress and are useful serially, but are influenced by age, renal function and atrial fibrillation. Chronic troponin elevation, strain and CMR fibrosis identify myocardial damage, without by themselves constituting universally validated indications for intervention.

Global cardiac damage includes left atrial enlargement, elevated pulmonary pressure, functional mitral regurgitation, right ventricular dysfunction and atrial fibrillation. These findings indicate that valve disease has progressed beyond isolated ventricular compensation. Coronary artery disease, amyloidosis and hypertension may contribute; attributing every abnormality to the aortic valve risks both premature unnecessary intervention and underestimating a valve lesion that is truly driving the condition.

Cohorts of patients with at least moderate stenosis and regurgitation have shown high rates of symptoms, valve replacement and death. In studies of initially asymptomatic patients with preserved function, peak aortic velocity predicted events better than valve area or the isolated grade of regurgitation. The message is not that every moderate form requires intervention, but that it should not be followed with the same inertia applied to two independent moderate lesions.

Observational evidence is vulnerable to selection and treatment bias: patients referred for replacement differ from those managed conservatively, and definitions of mixed disease are not uniform. The benefit associated with intervention does not automatically prove causality in every subgroup. The most recent recommendations therefore select phenotypes with objective consequences, while close surveillance and prospective studies remain central for the others.

Progression may involve calcification and valve area, regurgitation due to loss of coaptation, the aorta and the myocardium. Because gradients and volumes change with blood pressure and flow, a single measurement does not define the rate of progression. Serial studies in the same laboratory, image review and assessment under compensated conditions help distinguish biological change from technical variability.

Bicuspid valve disease introduces risks of aneurysm, dissection and heritability. Aortic diameters are measured at standardized segments and indexed when appropriate; CT or CMR provides confirmation when echocardiography is incomplete. The indication for aortic surgery depends on diameter, growth, family history, coarctation and the opportunity for concomitant valve replacement, not on hemodynamic severity alone.

Echocardiography and multimodality confirmation

Transthoracic echocardiography should assess stenosis and regurgitation separately and then verify their consistency with the ventricular response. For the stenotic component, Vmax, mean and peak gradients, velocity-time integrals, valve area by the continuity equation and the dimensionless index are measured. Left ventricular outflow tract diameter and Doppler alignment are important sources of error; multiple acoustic windows are used, including the right parasternal window when needed.

Regurgitation is graded by integrating vena contracta, flow convergence, jet characteristics, continuous-wave Doppler density and deceleration slope, holodiastolic flow reversal in the descending aorta, volumes and regurgitant fraction. An eccentric wall-adherent jet may appear small. Pressure half-time is influenced by compliance and pressures; a short value is not specific when left ventricular end-diastolic pressure is elevated.

The continuity equation calculates an effective valve area and remains useful, but regurgitation increases the volume crossing both the outflow tract and the valve: in the absence of measurement error, reflux should not falsely reduce calculated valve area. Velocity and gradient, by contrast, rise with total flow. Discordance between a moderate valve area and a severe-range Vmax may therefore be physiologically plausible and represent the combined burden rather than a reason to automatically disregard the velocity.

Echocardiographic volumetric quantification of regurgitation is based on the difference between total and effective stroke volume, but small errors in measuring outflow tract diameter are amplified because the value is squared. Aortic PISA is also technically complex and less robust than in other applications. When methods disagree, the report should state which parameters are reliable and, when necessary, use an independent modality rather than selecting the number most favorable to a predetermined conclusion.

The ventricle is assessed with biplane volumes, diameters, mass, ejection fraction and strain. Hypertrophy may limit the dilatation expected from regurgitation, and end-systolic volume may increase before an extreme diameter is reached. Ejection fraction must be interpreted in context: a fall below 50% not attributable to another cause is a strong signal in recommendations for mixed disease.

Blood pressure is part of the examination conditions and should always be recorded. Hypertension increases afterload and may accentuate regurgitation, whereas hypotension lowers gradients and may mask severity; atrial fibrillation and ectopy also require averaging comparable beats, and high output from anemia may increase Vmax. If a single measurement is expected to determine intervention, reversible conditions should be corrected and the finding confirmed before the decision.

Cardiac magnetic resonance is indicated when echocardiographic quality, regurgitation severity or ventricular volumes are discordant. Cine imaging quantifies volumes and mass, aortic phase-contrast imaging measures forward and reverse flow, and late enhancement characterizes scar; interstitial fibrosis can be estimated with mapping. Arrhythmias, the measurement plane and vortical flow require quality control and comparison with ventricular stroke volume.

Non-contrast CT quantifies aortic valve calcium using sex-specific thresholds to support stenosis severity in discordant cases. Calcium scoring characterizes the stenotic component; it does not quantify regurgitation or the mixed load. CT angiography assesses the root, ascending aorta, coronary arteries and TAVI access; in bicuspid valve disease it analyzes the raphe, calcium distribution and annular shape.

Exercise testing is appropriate in patients who report being asymptomatic, provided it is performed in an experienced setting. Symptoms, blood pressure response or abnormal exercise capacity clarify clinical status; exercise echocardiography may show an increase in gradient and pulmonary pressure, but no specific cutoffs are universally validated for every mixed phenotype. Catheterization is reserved for persistent discordance or coronary assessment and does not replace a well-performed Doppler study.

Surveillance, prognosis and indications for intervention

If stenosis or regurgitation is severe, the patient is managed according to the indications for the severe component, adapted to the concomitant load. Attributable symptoms, ventricular dysfunction and surgery for aortic or other disease are major decision points. In balanced forms, the 2025 European guidelines recognize that a moderate-moderate combination may require treatment before either defect becomes severe in isolation.

With moderate stenosis and moderate regurgitation, intervention is recommended in symptomatic patients when the mean gradient is at least 40 mmHg or Vmax is at least 4.0 m/s, after confirming that symptoms are valve-related. Velocity reflects both increased flow and obstruction; it should not be downgraded solely because valve area is larger than in isolated severe stenosis.

In the same combination, intervention is also recommended in asymptomatic patients with Vmax at least 4.0 m/s and ejection fraction below 50%, when dysfunction is not explained by another disease. Ischemia, cardiomyopathy, arrhythmia and hypertension must be investigated. An ejection fraction just above this threshold, without symptoms or progression, does not automatically mandate the procedure.

In asymptomatic patients who do not yet meet criteria for intervention, surveillance is generally closer than for a single moderate lesion. The frequency of visits and echocardiograms depends on Vmax, progression rate, regurgitation severity, ventricular response and aortic status and, in more advanced phenotypes, may become every six months. Exercise testing and biomarkers help uncover early change, whereas dyspnea, angina, syncope or reduced activity should prompt the patient not to wait for the scheduled visit.

Blood pressure is treated carefully: reducing afterload is useful in regurgitation and for vascular risk, but excessive hypotension is poorly tolerated in important stenosis. No drug halts calcification or replaces intervention. Diuretics relieve congestion, whereas statins are indicated for atherosclerotic risk rather than to slow calcific valve disease.

Individual prognosis integrates trajectory, not only thresholds. Rising Vmax, increasing end-systolic volumes, worsening strain and new symptoms form a more compelling pattern than a single borderline value. If measurements change abruptly without clinical evolution, blood pressure, rhythm, anemia, technique and image quality should be checked before declaring progression.

Pregnancy and non-cardiac surgery require specific risk stratification. When possible, severe or symptomatic mixed valve disease should be corrected before conception, also considering any bicuspid-associated aortopathy; before major surgery, the plan instead depends on the relative weight of stenosis and regurgitation, ventricular function and procedural urgency. The label “mixed disease” alone does not define risk.

SAVR, TAVI and follow-up after replacement

Surgical replacement treats stenosis and regurgitation simultaneously and allows intervention on the aortic root, ascending aorta, coronary arteries or other valves. It is particularly suitable for younger patients, bicuspid valve disease with aortopathy, anatomy unfavorable for TAVI or a need for bypass surgery. The choice between a mechanical and bioprosthetic valve takes into account age, anticoagulation, pregnancy, life expectancy and the possibility of future procedures.

TAVI is an option when the stenotic component provides adequate calcification and anchoring and the patient meets general indications for transcatheter replacement. This should not be confused with treatment of isolated non-calcific regurgitation, which carries a greater risk of migration and leak. CT defines the annulus, coronary arteries, calcium, root and access; bicuspid anatomy and asymmetric calcium require particular judgment.

Observational studies and meta-analyses indicate that survival outcomes after TAVI in mixed disease with severe stenosis are at least comparable to those in predominant stenosis. Pre-existing regurgitation may precondition the ventricle to increased stroke volume, but it is not clinically protective. Post-TAVI paravalvular leak is more frequent or more harmful in some studies and should be prevented through appropriate sizing and assessed rigorously.

The SAVR-TAVI choice is made by the Heart Team considering biological age, risk, anatomy, coronary disease, aorta, access, durability and preferences. Mixed aortic valve disease does not by itself determine the route. A young patient with bicuspid valve disease and a dilated aorta gains little from a procedure that leaves the aortopathy untreated; an older patient with a normal aorta and favorable access may avoid surgical trauma.

After valve replacement, the ventricle undergoes a rapid hemodynamic change because the afterload imposed by stenosis decreases and the volume overload of regurgitation disappears. End-diastolic volume and mass tend to decrease progressively, whereas ejection fraction may vary according to true contractility; persistent dysfunction may reflect fibrosis, ischemia, mismatch or late intervention. The baseline post-procedural examination therefore documents gradients, any leaks, ventricular function and residual aortic dimensions.

Prosthetic valve surveillance looks for structural deterioration, thrombosis, endocarditis, mismatch and paravalvular regurgitation. A gradient that is high from baseline differs from one that rises over time; new regurgitation is not recurrence of native valve disease but a prosthetic dysfunction that must be characterized. Echocardiography, CT and sometimes CMR are selected according to the clinical question.

The aorta continues to require imaging if it was dilated or the valve was bicuspid, even after valve replacement. Blood pressure, oral hygiene, physical activity, anticoagulation and endocarditis prophylaxis are managed according to prosthesis and risk. Success is not merely a normal Vmax: it includes regression of remodeling, absence of symptoms, a stable aorta, good durability and a realistic lifetime strategy.